A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 14,200 shares of BHC stock, worth $98,974. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,200
Previous 16,300 12.88%
Holding current value
$98,974
Previous $130,000 15.38%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $16,317 - $22,281
-2,100 Reduced 12.88%
14,200 $150,000
Q4 2023

Feb 13, 2024

SELL
$6.53 - $8.23 $6,530 - $8,230
-1,000 Reduced 5.78%
16,300 $130,000
Q2 2023

Aug 10, 2023

SELL
$5.72 - $8.8 $4,576 - $7,040
-800 Reduced 4.42%
17,300 $138,000
Q4 2022

Feb 13, 2023

BUY
$6.09 - $7.93 $18,879 - $24,583
3,100 Added 20.67%
18,100 $113,000
Q3 2022

Nov 10, 2022

BUY
$4.58 - $9.21 $22,900 - $46,050
5,000 Added 50.0%
15,000 $103,000
Q2 2022

Aug 12, 2022

SELL
$7.06 - $23.63 $48,008 - $160,684
-6,800 Reduced 40.48%
10,000 $84,000
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $12,520 - $15,030
-500 Reduced 2.89%
16,800 $468,000
Q2 2021

Aug 13, 2021

SELL
$27.43 - $32.7 $46,631 - $55,590
-1,700 Reduced 8.95%
17,300 $507,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $149,590 - $240,660
-7,000 Reduced 26.92%
19,000 $603,000
Q4 2020

Feb 05, 2021

SELL
$15.31 - $21.12 $50,523 - $69,696
-3,300 Reduced 11.26%
26,000 $541,000
Q3 2020

Nov 06, 2020

BUY
$14.88 - $20.13 $130,944 - $177,144
8,800 Added 42.93%
29,300 $455,000
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $59,895 - $92,295
4,500 Added 28.13%
20,500 $375,000
Q1 2020

May 14, 2020

BUY
$12.98 - $30.25 $80,476 - $187,550
6,200 Added 63.27%
16,000 $248,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $37,780 - $63,780
-2,000 Reduced 16.95%
9,800 $293,000
Q3 2019

Nov 01, 2019

BUY
$20.88 - $25.66 $246,384 - $302,788
11,800 New
11,800 $258,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.52B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.